The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
NeuACT, a phase II, randomized, open-label trial of DN24-02: Updated analysis of HER2 expression, immune responses, product parameters, and safety in patients with surgically resected HER2+ urothelial cancer.
Dean F. Bajorin
Research Funding - Dendreon
Other Remuneration - Dendreon
Padmanee Sharma
Employment or Leadership Position - SITC (U)
Consultant or Advisory Role - Bristol-Myers Squibb; Dendreon; Helsinn Therapeutics; Jounce Therapeutics; MedImmune
Stock Ownership - Jounce Therapeutics
Research Funding - Bristol-Myers Squibb
Leonard G. Gomella
Consultant or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen
Research Funding - Astellas Pharma; Dendreon; Janssen
Elizabeth R. Plimack
Consultant or Advisory Role - Dendreon
Research Funding - Dendreon
Peter H. O'Donnell
Honoraria - Dendreon
Jean H. Hoffman-Censits
No relevant relationships to disclose
Thomas W. Flaig
Honoraria - Sanofi
Research Funding - Dendreon; Sanofi ; Veridex
Other Remuneration - Aurora Oncology
David I. Quinn
Consultant or Advisory Role - Dendreon
Honoraria - Dendreon
Robert Brownell Sims
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Michael Locker
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Nadeem A. Sheikh
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Todd DeVries
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Seth P. Lerner
No relevant relationships to disclose